Achieved the largest market share in the domestic artificial breast implant market
Completed the construction of the first artificial breast implant automation facility (smart factory) in the world
Established Hans Biomed U.K
Established Hans Biomed Mexico
Constructed a high-tech medical equipment research center
Signed a contract on the transfer of neural stem cell culture technology with the College of Medicine, Yonsei University
Acquired BNA Med, the sales business of the domestic plastic surgery clinic
Merged Cosmeceutical Zitones Bio and Hans Pharma
Established Hans Care, a sales business for the domestic plastic clinics
Established Hans Biomed Thailand
Constructed Munjeong new office building (Seoul) of Hand Biomed Co/. Ltd.
Licensed to manufacture and sell BellaGel SmoothFine by MFDS
Licensed to manufacture and sell MINT Easy & Fine by MFDS
Constructed a research center for cell therapy products (Seoul)
Licensed to sell “BellaGel” (artificial breast implant) from Chinese National Medical Products Administration (CNMPA)
Licensed to manufacture and sell artificial breast implants 'BellaGel' by MFDS
Established “Hans Pharma” a subsidiary of Hans Biomed Co. in the field of cosmeceutical market.
Established Shanghai Hans Biomed Corp.
Licensed to manufacture and sell Mint Lift facial tissue fixing sutures by MFDS
Awarded "$10 Million Export Tower” on the 51st Trade Day
Licensed to manufacture and sell XenoDerm by MFDS
Licensed to manufacture and sell Scar Clinic (gel-type scare care product) by MFDS
Extended Hans Daeduk Research Center (the tissue engineering research lab)
Awarded "$5 Million Export Tower" on the 20th Trade Day
Hans Biomed's tissue bank accredited by AATB ((American Association of Tissue Banks)
The patent of "Bone Filler Loading Extended Release Type Drug for Treating Osteoporosis" registered.
Established Hans Biomed USA Inc.
Listed on KOSDAQ, the first in the industry
Artificial breast registered for CE
Awarded "$ 1Million Export Tower" (KTA)
Commercialized DBM (Demineralized Bone Matrix)
(Product Name: SuerFuseTM-Gel/Putty, ExFuseTM-Gel/Putty)
Acquired permission for establishing the first 'tissue bank' in Korea from MFDS
Launched “Scar Clinic” (a scar care product) first in Korea
Registered a human tissue transplant to the U.S. FDA
Constructed Hans Deduk Research Center (tissue engineering research lab) on a total floor area of 2,644m2 (as of now, 5.950m2)
Established Japan Hans Biomed Co. Ltd.
Developed SuerDerm TM (Acellular Dermal Matrix)
Established HITE Hans Institute of Tissue Engineering
Established Hans Medical Co., Ltd.
Researched and developed acellular dermis with KAIST
Produced compression clothing exclusive for burn treatment and liposuction surgery